News

Northern 3 VCT Reports Strong Growth Amid Economic Challenges

Northern 3 VCT Reports Strong Growth Amid Economic Challenges

Northern 3 VCT Sees Promising Financial Results

Northern 3 VCT PLC is a well-established Venture Capital Trust under the expert management of Mercia Fund Management Limited. This entity primarily focuses on investing in unquoted venture capital holdings, aiming to secure long-term tax-free returns for its shareholders through a dynamic blend of dividend yield and capital appreciation.

Financial Highlights Overview

As of the latest reports, the financial status of Northern 3 VCT has demonstrated considerable strength compared to the previous fiscal year. The net assets are recorded at £130.1 million, reflecting an increase from £122.5 million reported last year.

Key Metrics

The net asset value (NAV) per share has seen a positive movement to 90.0p from 89.3p, indicating an upward trend in value. The total return per share has also improved significantly, rising to 4.8p compared to 2.2p in the prior period.

Dividends Declared

The Board of Directors has proposed a final dividend of 2.5p per share, building upon an interim dividend of 2.0p delivered earlier in the year. This remains aligned with the Company's target of a 4.5% annual dividend yield based on the opening NAV.

Investment Portfolio Updates

Northern 3 VCT's investment portfolio has experienced satisfactory growth throughout the year. Notably, both the Pure Pet Food and Project Glow Topco investments saw their valuations increase by over £3 million.

Within the venture portfolio, sales generated an impressive £9.9 million from an initial investment of £8.1 million. A standout performance was the sale of Gentronix, which netted £3.6 million, vastly exceeding its original cost of £0.8 million — equivalent to a return of 4.5 times.

During the year, £9.5 million was allocated towards six new venture capital investments, with an additional £5.4 million invested as follow-on funding to support existing ventures.

Share Offer Progress and Liquidity Management

In line with its strategic objectives, in April, Northern 3 VCT issued 11.7 million new ordinary shares from its 2023/24 share offer, which raised approximately £11 million. Subsequently, the Company launched another public share offer in January 2025, resulting in 6.6 million new shares issued, garnering gross proceeds of £6 million.

The Board has meticulously monitored liquidity and has planned to raise up to £20 million in the upcoming tax year to support further investment strategies. The proposal includes a base offer of £14 million and an overallotment facility potentially reaching an additional £6 million.

Share Buyback Policy

The Company has continued its share buyback policy, permitting repurchases to enhance liquidity. A total of 5,161,691 shares were executed during the last fiscal period, approximately 3.8% of the opening share capital.

Commitment to Responsible Investment

As part of its commitment to responsible investment, Northern 3 VCT adheres to Environmental, Social, and Governance (ESG) responsibilities. This commitment is discussed in detail within the annual report.

Leadership Changes

In a noteworthy expansion of its governance, David Ovens joined the Board as a non-executive director in April 2025, leveraging his 30 years of investment experience and enhancing the Board's expertise.

Regulatory Standing

The Company has maintained its compliance with the rigorous qualifying conditions stipulated by HM Revenue & Customs for VCT approval. This enables the continuation of tax relief benefits for investors, vital for attracting further investment.

Outlook for Growth

Despite facing pressures from fluctuating global markets and local economic conditions, Northern 3 VCT's management projects a positive outlook. The firm remains optimistic about its growth trajectory, underpinned by high-quality investment opportunities and a robust portfolio prepared for the evolving landscape.

Future Reports

The full annual report with comprehensive financial statements for the year ending 31 March will be available to shareholders shortly. It underlines the commitment to transparency and shareholder engagement, central to Northern 3 VCT's operational ethos.

Frequently Asked Questions

1. What was the net asset value per share for Northern 3 VCT?

The net asset value per share increased to 90.0p as of the latest report.

2. How much did Northern 3 VCT raise from recent share issues?

Northern 3 VCT raised approximately £11 million from its share offer in April 2024 and an additional £6 million from the public share offer in January 2025.

3. What is the proposed dividend amount for shareholders?

The Board has proposed a final dividend of 2.5p per share, in addition to the interim dividend of 2.0p already declared.

4. Who has joined the Board recently?

David Ovens joined the Board as a non-executive director in April 2025, bringing extensive investment experience.

5. How does Northern 3 VCT plan to manage economic risks?

The Company employs a diversified portfolio approach and maintains strong cash reserves to tackle emerging economic challenges and investment opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 120

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 710

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 20

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 179

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 312

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 474

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 134

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Traditions Bancorp Declares New Cash Dividend for Investors

Updated Category News Views 76

Traditions Bancorp Declares Quarterly Cash Dividend On a recent date, the Board of Directors of Traditions Bancorp (OTC: TRBK), the parent company of Traditions Bank, announced a quarterly cash dividend of eight cents per common share. This dividend reflects the company's strong commitment to returning value to its shareholders and will be disbursed shortly. The payment...

Continue Reading
LONGi BC Tech Paves the Way for Solar Leadership in Europe

Updated Category News Views 334

LONGi's Impact on Europe's Solar Industry LONGi, recognized as a leader in solar technology, has made remarkable strides in reshaping the renewable energy scene in Europe. With an impressive 10GW of back contact (BC) modules deployed, the continent is rapidly becoming a hotbed for high-efficiency solar solutions. This accomplishment underlines the company's crucial...

Continue Reading
PACS Group Investors: Important Actions to Take Now

Updated Category News Views 152

Important Deadline for PACS Group Investors Investors in PACS Group, Inc. are advised to take note of an important lead plaintiff application deadline related to recent securities class action lawsuits. If you have incurred losses exceeding $100,000 in the company's stock, you may be eligible to participate in these legal proceedings. Class Action Lawsuit Details The...

Continue Reading
Exploring Market Sentiment Around Morningstar Inc and Its Trends

Updated Category News Views 207

Understanding Morningstar Inc's Market Position Morningstar Inc (NYSE:MORN) has recently shown a notable decline in its short interest, with a decrease of 9.22% reported. Currently, there are approximately 655 thousand shares sold short, constituting about 2.56% of the total shares available for trading. This information is pivotal for investors since it reflects the...

Continue Reading
Julie Springer Expands Legal Services with Mediation Practice

Updated Category News Views 363

Julie Springer's New Ventures in Mediation In the dynamic legal scene of Austin, seasoned attorney Julie A. Springer is making waves by broadening her practice to include mediation and arbitration services. This thoughtful transition reflects her long-time dedication to effectively settling business disputes, educational conflicts, and employment issues. Professional...

Continue Reading